110 related articles for article (PubMed ID: 37598576)
41. A population survey on beliefs around cervical cancer screening: determining the barriers and facilitators associated with attendance.
Judah G; Dilib F; Darzi A; Huf S
BMC Cancer; 2022 May; 22(1):522. PubMed ID: 35534802
[TBL] [Abstract][Full Text] [Related]
42. Cervical cancer screening coverage and its related knowledge in southern Malawi.
Gerstl S; Lee L; Nesbitt RC; Mambula C; Sugianto H; Phiri T; Kachingwe J; Llosa AE
BMC Public Health; 2022 Feb; 22(1):295. PubMed ID: 35164716
[TBL] [Abstract][Full Text] [Related]
43. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
Della Palma P; Moresco L; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
[TBL] [Abstract][Full Text] [Related]
44. Association Between Cervical Cancer Screening Guidelines and Preterm Delivery Among Females Aged 18 to 24 Years.
Bromley-Dulfano RA; Rossin-Slater M; Bundorf MK
JAMA Health Forum; 2023 Jul; 4(7):e231974. PubMed ID: 37477927
[TBL] [Abstract][Full Text] [Related]
45. Unindicated cervical cancer screening in adolescent females within a large healthcare system in the United States.
Hosier H; Sheth SS; Oliveira CR; Perley LE; Vash-Margita A
Am J Obstet Gynecol; 2021 Dec; 225(6):649.e1-649.e9. PubMed ID: 34256029
[TBL] [Abstract][Full Text] [Related]
46. Increasing cervical cancer screening in Iran: effectiveness of a theory-based educational intervention.
Hosseini Z; Mohseni S; Momeni R; Aghamolaei T; Alavi A; Dadipoor S
Reprod Health; 2022 Sep; 19(1):186. PubMed ID: 36050727
[TBL] [Abstract][Full Text] [Related]
47. The influence of knowledge and perception of the risk of cervical cancer on screening behavior in mainland Chinese women.
Gu C; Chan CW; Twinn S; Choi KC
Psychooncology; 2012 Dec; 21(12):1299-308. PubMed ID: 23208838
[TBL] [Abstract][Full Text] [Related]
48. Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey.
Constantinou P; Dray-Spira R; Menvielle G
BMC Cancer; 2016 Mar; 16():255. PubMed ID: 27029643
[TBL] [Abstract][Full Text] [Related]
49. Factors associated with and socioeconomic inequalities in breast and cervical cancer screening among women aged 15-64 years in Botswana.
Keetile M; Ndlovu K; Letamo G; Disang M; Yaya S; Navaneetham K
PLoS One; 2021; 16(8):e0255581. PubMed ID: 34347841
[TBL] [Abstract][Full Text] [Related]
50. Cervical cancer screening outcomes in Zambia, 2010-19: a cohort study.
Pry JM; Manasyan A; Kapambwe S; Taghavi K; Duran-Frigola M; Mwanahamuntu M; Sikazwe I; Matambo J; Mubita J; Lishimpi K; Malama K; Bolton Moore C
Lancet Glob Health; 2021 Jun; 9(6):e832-e840. PubMed ID: 34019837
[TBL] [Abstract][Full Text] [Related]
51. Personal factors influence use of cervical cancer screening services: epidemiological survey and linked administrative data address the limitations of previous research.
Olesen SC; Butterworth P; Jacomb P; Tait RJ
BMC Health Serv Res; 2012 Feb; 12():34. PubMed ID: 22333392
[TBL] [Abstract][Full Text] [Related]
52. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
[TBL] [Abstract][Full Text] [Related]
53. Social network characteristics and cervical cancer screening among Quechua women in Andean Peru.
Luque JS; Opoku S; Ferris DG; Guevara Condorhuaman WS
BMC Public Health; 2016 Feb; 16():181. PubMed ID: 26911388
[TBL] [Abstract][Full Text] [Related]
54. Interventions targeted at women to encourage the uptake of cervical screening.
Staley H; Shiraz A; Shreeve N; Bryant A; Martin-Hirsch PP; Gajjar K
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD002834. PubMed ID: 34694000
[TBL] [Abstract][Full Text] [Related]
55. Cervical cancer screening in rural Ethiopia: a cross- sectional knowledge, attitude and practice study.
Ruddies F; Gizaw M; Teka B; Thies S; Wienke A; Kaufmann AM; Abebe T; Addissie A; Kantelhardt EJ
BMC Cancer; 2020 Jun; 20(1):563. PubMed ID: 32552740
[TBL] [Abstract][Full Text] [Related]
56. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
57. Medicaid expansions and differences in guideline-adherent cervical cancer screening between American Indian and White women.
Gartner DR; Islam JY; Margerison CE
Cancer Med; 2023 Apr; 12(7):8700-8709. PubMed ID: 36629351
[TBL] [Abstract][Full Text] [Related]
58. Utilization of cervical cancer screening services and its associated factors among primary school teachers in Ilala Municipality, Dar es Salaam, Tanzania.
Kileo NM; Michael D; Neke NM; Moshiro C
BMC Health Serv Res; 2015 Dec; 15():552. PubMed ID: 26666242
[TBL] [Abstract][Full Text] [Related]
59. Cervical cancer screening service utilization and associated factors among HIV positive women attending adult ART clinic in public health facilities, Hawassa town, Ethiopia: a cross-sectional study.
Assefa AA; Astawesegn FH; Eshetu B
BMC Health Serv Res; 2019 Nov; 19(1):847. PubMed ID: 31744548
[TBL] [Abstract][Full Text] [Related]
60. Low Coverage and Disparities of Breast and Cervical Cancer Screening in Thai Women: Analysis of National Representative Household Surveys.
Mukem S; Meng Q; Sriplung H; Tangcharoensathien V
Asian Pac J Cancer Prev; 2015; 16(18):8541-51. PubMed ID: 26745114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
